IUPAC Name
(±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine
Current Scheduling Status
Schedule I of the 1961 Convention
Year(s) and type of review / ECDD meetings
None
Drug Class